Nutrition 21 Announces Canadian Approval of Chromium Picolinate for Use in Natural Health Products

PURCHASE, N.Y., Feb 24, 2010 /PRNewswire via COMTEX/ -- Nutrition 21, Inc. , the developer and marketer of nutritional ingredients for the dietary supplement, functional food and beverage markets announced today that chromium picolinate has been officially approved for sale in Canada as a natural health product by Health Canada, the Canadian federal agency devoted to maintaining and improving the health of the nation's citizens. As a result of this approval, Nutrition 21 can now sell its Chromax(R) brand of chromium picolinate to Canadian manufacturers, marketers, and importers of natural health products.

Natural health products (referred to as dietary supplements in the U.S.) require approval from Health Canada prior to marketing in Canada. After reviewing the safety and efficacy of chromium picolinate, Health Canada issued a revised monograph which now allows applicants access to an expedited licensing process taking less than 60 days. This process can help manufacturers more quickly get chromium picolinate products into the Canadian market.

"Chromium picolinate is now the only organically bound chromium approved for sale in U.S., European Union, and Canadian markets," stated William J. Levi, vice president, Ingredients and Special Markets. "We are delighted to be informed of the Canadian approval of chromium picolinate, which now allows us to expand sales of our Chromax(R) ingredient to natural health product manufacturers and marketers servicing the Canadian market."

Michael A. Zeher, president and chief executive officer of Nutrition 21, Inc., added, "Access to new markets worldwide provides Nutrition 21 with a strong platform to accelerate expansion of our ingredients business and is consistent with our new strategic growth plans. Chromium picolinate's regulatory approval in Canada and the European Union provides further credence to the product's safety and utility."

About Nutrition 21

Nutrition 21, Inc. (OTC:BB: NXXI.OB), headquartered in Purchase, NY, is a nutritional bioscience company and holds over 30 issued and pending patents associated with chromium picolinate as well as combinations of chromium compounds with other dietary supplement ingredients. Its ingredients are sold to leading dietary supplement, functional food and beverage manufacturers. For more information please visit

Safe Harbor Provision

This press release may contain certain forward-looking statements. The words "believe," "expect," "anticipate" and other similar expressions generally identify forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of their dates. These forward-looking statements are based largely on the Company's current expectations and are subject to a number of risks and uncertainties, including without limitation: the effect of the expiration of patents; regulatory issues; uncertainty in the outcomes of clinical trials; changes in external market factors; changes in the Company's business or growth strategy or an inability to execute its strategy due to changes in its industry or the economy generally; the emergence of new or growing competitors; various other competitive factors; and other risks and uncertainties indicated from time to time in the Company's filings with the Securities and Exchange Commission, including its Form 10-K/A for the year ended June 30, 2009. Actual results could differ materially from the results referred to in the forward-looking statements. In light of these risks and uncertainties, there can be no assurance that the results referred to in the forward-looking statements contained in this press release will in fact occur. Additionally, the Company makes no commitment to disclose any revisions to forward-looking statements, or any facts, events or circumstances after the date hereof that may bear upon forward-looking statements.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.